Literature DB >> 28145160

The THUNDERBEAT system for tissue dissection and vascular control in laparoscopic splenectomy.

Silvia Ceccanti1, Ilaria Falconi1, Simone Frediani1, Alessandro Boscarelli1, Marco Catani2, Denis A Cozzi1.   

Abstract

The advent of new energy sources for hemostasis has greatly facilitated advanced laparoscopic procedures. We describe a straightforward technique of laparoscopic splenectomy (LS) accomplished using the THUNDERBEAT™ system (TS) (Olympus Medical Systems Corp., Tokyo, Japan) as the sole means of tissue dissection and hemostasis in two patients aged 19 and 6 years, respectively. The specimens were removed intact via a Pfannenstiel incision. Total operative time was 165 and 150 min, and length of hospital stay was three and 4 d, respectively. The TS is an appealing and reliable alternative to currently available energy devices, allowing fast dissection and secure hemostasis during laparoscopic splenectomy.

Entities:  

Keywords:  Laparoscopic splenectomy; THUNDERBEATTM system; children; three-trocar technique; vessel sealing device

Mesh:

Year:  2017        PMID: 28145160     DOI: 10.1080/13645706.2017.1281314

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706            Impact factor:   2.442


  2 in total

1.  Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation.

Authors:  Claudio Gambardella; Guglielmo Clarizia; Renato Patrone; Chiara Offi; Claudio Mauriello; Roberto Romano; Marco Filardo; Alessandra Conzo; Alessandro Sanguinetti; Andrea Polistena; Nicola Avenia; Giovanni Conzo
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

2.  A pilot randomized controlled trial comparing THUNDERBEAT to the Maryland LigaSure energy device in laparoscopic left colon surgery.

Authors:  Jeffrey W Milsom; Koianka Trencheva; Kota Momose; Miroslav P Peev; Paul Christos; Parul J Shukla; Kelly Garrett
Journal:  Surg Endosc       Date:  2021-11-01       Impact factor: 3.453

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.